Previous 10 | Next 10 |
Ahead of the launch of its first product, ChemoCentryx (NASDAQ:CCXI) has bolstered its executive team with the appointment of Rita I. Jain as the company’s new chief medical officer. Dr. Jain a board-certified rheumatologist with over 20 years of experience in drug development, will al...
Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness THE POWER OF YOU CAMPAIGN ADVOCATES FOR AWARENESS AND EMPOWERS CONFIDENCE PR Newswire IRVINE, Calif. , Oct. 11, 2021 /PRNewswire/ -- Allergan Aesthetics, an Abb...
The portfolio targets 3% initial dividend yields and 7% dividend growth. Hybridizing companies is often used to reach the target. Income was boosted by several increases in September and is now projected at $13,605 for 2021. As prices fell in September, additions were made to Lock...
We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date. We highlight a high-quality stock with an upcoming ex-dividend date. For further details see: Upcom...
I made 4 transactions during the month. Dividends were up approximately $55. Forward dividend is now $779. For further details see: My Portfolio September Update - 4 Buys
In 2015, I started publishing quarterly updates regarding my dividend growth portfolio. I believe that someone who writes about financial assets should share his main holdings with his readers. In this article, I will share my portfolio, changes in the past 3 months and stocks tha...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Kiplinger "insights for investors" online first offered a list of 91 "Top Dividend Stocks From Around The World" 7/13/20. Two Kiplinger articles provided this 102 Top Dividend Stocks list 7/1/21. 39 European “Dividend Aristocrats” showed 10 years of stable or increasing ...
MRNA and ABBV have come under pressure over the last two months due to news items that could spell trouble. The two companies are very different when it comes to diversification, pipeline strength, and their respective two-year outlook. Both stocks look inexpensive at first sight,...
Health Canada Approves the Use of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis Canada NewsWire Authorization is based on the results from three Phase 3 multicenter, randomized, double-blind, placebo...
News, Short Squeeze, Breakout and More Instantly...
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company. The analyst notes that the company has ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® PR Newswire - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancin...